Acebrophylline is a xanthine derivative with anti-inflammatory and mucoregulating properties. It improves mucus clearance and reduces airway inflammation in COPD and asthma. AMBROXOL ACEFYLLINATE is a small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication. It is grouped under the following drug class(es): Bronchodilators. Its therapeutic use is listed as anti-asthmatic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Ambromucil, Broncomnes and Ambroxol acefyllinate. Its PubChem CID is 176595.
Acebrophylline
| CAS No | 96989-76-3 |
|---|---|
| Molecular Formula | C22H28Br2N6O5 |
| Molecular Weight | 616.3 g/mol |
| Synonyms | 4-[(2-amino-3,5-dibromophenyl)methylamino]cyclohexan-1-ol;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Acebrophylline is a xanthine derivative with anti-inflammatory and mucoregulating properties. It improves mucus clearance and reduces airway inflammation in COPD and asthma.
The listed CAS number is 96989-76-3.
The listed molecular formula is C22H28Br2N6O5.
The listed molecular weight is 616.3 g/mol.
4-[(2-amino-3,5-dibromophenyl)methylamino]cyclohexan-1-ol;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetic acid.
The source lists Ambromucil, Broncomnes and Ambroxol acefyllinate.